“Evaluating Effectiveness of Deferasirox Versus Deferoxamine in Improving Clinical Outcomes among Patients with Transfusion-Dependent Thalassemia: A Randomized Controlled Trial”, LMJHCR, vol. 3, no. 2, pp. 1–12, Dec. 2025, doi: 10.61919/e41dwh72.